Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-678P is a processed pseudogene copy of the U6 snRNA gene, which constitutes a small nuclear RNA sequence. Unlike functional U6 snRNA, which is essential in the spliceosome for pre-mRNA splicing in eukaryotes[1][3], RNU6-678P is a non-functional genomic relic, formed through retrotransposition via LINE-1 and other mechanisms[2]. Pseudogenes like RNU6-678P are not transcribed into functional products nor do they encode for proteins. They serve as genomic markers for studying retrotransposon activity and genome evolution but do not participate in biological processes, regulatory functions, or disease mechanisms[2]. The ubiquitous presence of such pseudogenes reflects evolutionary genome dynamics rather than functional or therapeutic relevance[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 678, pseudogene (RNU6-678P).